How has Praxis Precision Medicines, Inc.'s stock issuance proceeds changed year-over-year?

Praxis Precision Medicines, Inc.'s stock issuance proceeds increased by 99.8% year-over-year, from $560K to $1.12M.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Praxis Precision Medicines, Inc. PRAX Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Jazz PharmaceuticalsJAZZ

$32.9M+186%

Axsome TherapeuticsAXSM

$6.34M-67.7%

AlkermesALKS

$15.71M-46.8%

Neurocrine BiosciencesNBIX

$23.6M-26.5%

TG TherapeuticsTGTX

$763K+3,533%

Rhythm Pharmaceuticals, Inc.RYTM

——

Other financials

Income statement

See full

Revenue--100%

Operating income-$105.9M-41.7%

Net income-$92.6M-33.6%

EPS (diluted)-$3.20+2.7%

Balance sheet

See full

Cash & equivalents$536.7M+223%

Total debt$1.4M+31.3%

Total equity$1.4B+221%

Total assets$1.5B+205%

Cash flow

See full

Operating cash flow-$86.2M-62.5%

CapEx$62.0K—

Free cash flow-$86.2M-62.6%

Valuation

See full

Market cap$7.87B+1,075%

Enterprise value$7.34B+1,309%

Profitability

See full

Operating margin-3,927.5%-1,497pp

Net margin-3,658.5%-1,388pp

FCF margin-3,067.4%-1,030pp

Returns & leverage

See full

Return on equity-35.3%-10.9pp

Debt / equity0×0.0×

Current ratio15.9×+7.4×

Where this comes from

Reported directly by Praxis Precision Medicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Praxis Precision Medicines, Inc.'s stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Praxis Precision Medicines, Inc.'s stock issuance proceeds?: Praxis Precision Medicines, Inc. (PRAX) reported stock issuance proceeds of $1.12M in Q1 2026.
How has Praxis Precision Medicines, Inc.'s stock issuance proceeds changed year-over-year?: Praxis Precision Medicines, Inc.'s stock issuance proceeds increased by 99.8% year-over-year, from $560K to $1.12M.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.